| Primary information |
|---|
| ID | 13039 |
| Uniprot ID | Q9NIP6 |
| Description | Cardio acceleratory peptide 2b (Capability protein) (Myotropin-CAP2b-like protein) [Cleaved into- CAP-1 (CAP2b-1) (Capa-1); CAP-2 (CAP2b-2) (Capa-2); CAP-3 (CAP2b-3) (Capa-3) (Myotropin) (Pyrokinin-1)] |
| Organism | Drosophila melanogaster |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Protostomia; Ecdysozoa; Panarthropoda; Arthropoda; Mandibulata; Pancrustacea; Hexapoda; Insecta; Dicondylia; Pterygota (winged insects); Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Eremoneura; Cyclorrhapha; Schizophora; Acalyptratae; Ephydroidea; Drosophilidae (pomace flies); Drosophilinae; Drosophilini; Drosophila (fruit flies); Sophophora; melanogaster group; melanogaster subgroup; Drosophila melanogaster (Fruit fly) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the pyrokinin family. |
| Tissue Specificity | In larvae; the precursor peptide is exclusively present in a single pair of neuroendocrine cells in the labial neuromere (subesophageal ganglion) and three pairs of cells in the ventral ganglion abdom |
| Post Translational Modification | NA |
| Function | CAP-1 and CAP-2; but not CAP-3 are ligands for the Capa receptor |
| Length | 151 |
| Molecular Weight | 16 |
| Name | Cardio acceleratory peptide 2b |
| Sequence | ASGLVAFPRV |
| Sequence map | 240 |
| PDB ID | 11959669; 10731132; 12537572; 12537569; 12171930; 12177421; 12459185; 11179818; 16054112 |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|